跳至主要内容
临床试验/TCTR20191204004
TCTR20191204004尚未招募1 期

Safety of cannabidiol in Parkinson’s disease patient

Prasat Neurological Institute0 个研究点目标入组 10 人开始时间: 2019年12月4日最近更新:
适应症

试验速览

阶段
1 期
状态
尚未招募
发起方
入组人数
10

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
18 Years 至 95 Years(—)
性别
All

入选标准

  • 1) Stable Parkinson's disease patient with unchanged medications for at least 1 month before enrolling to the trial
  • 2) Parkinson's disease patient who tested for memory(TMSE)not more than 1 year and the score is not less than 23 bofore enrolling to the trial
  • 3) Parkinson's disease patient without cannabidiol usage within 1 month before enrolling to the trial
  • 4) Parkinson's disease patient with the age of over 18 years old
  • 5) Willing and able to give informed consent

排除标准

  • 1) Parkinson's disease patient with
  • -Psychiatric disease
  • -cardiovascular disease
  • -arrhythmia
  • -liver disease or abnormal liver function test(AST orALT more than 40 U/L
  • 2)Parkinson's disease patient who is pregnant or lactating
  • 3)Parkinson's disease patient who is not willing to participate in this trial

研究者

发起方
Prasat Neurological Institute

相似试验